Penumbra Inc
(STU:0P8)
€
242.6
2.7 (1.13%)
Market Cap: 9.57 Bil
Enterprise Value: 9.50 Bil
PE Ratio: 299.78
PB Ratio: 8.96
GF Score: 88/100 Penumbra Inc at Robert W Baird Global Healthcare Conference Transcript
Sep 12, 2023 / 06:00PM GMT
David Kenneth Rescott
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst
Good afternoon, everyone. 2023 Baird's Global Healthcare Conferences. I'm David Rescott, senior medtech analysts here at Baird. Pleased to have the Penumbra team with us, Jason Mills, EVP of Strategy. (Operator Instructions) So Jason, thanks for being here.
Jason Richard Mills
Penumbra, Inc. - EVP of Strategy
Yes. Thanks, Dave, for having us. First time at the Baird Conference.
David Kenneth Rescott
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst
Glad to have you. Hope for the next or two.
Jason Richard Mills
Penumbra, Inc. - EVP of Strategy
Thank you.
Questions & Answers
David Kenneth Rescott
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst
So let's start off maybe flashing back or looking back 2019, the goal was to achieve $1 billion
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot